Zomedica Corp. Quarterly Selling and Marketing Expense in USD from Q3 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Zomedica Corp. quarterly/annual Selling and Marketing Expense history and growth rate from Q3 2022 to Q2 2024.
  • Zomedica Corp. Selling and Marketing Expense for the quarter ending June 30, 2024 was $3.92M, a 27.3% increase year-over-year.
  • Zomedica Corp. annual Selling and Marketing Expense for 2023 was $3.42M, a 65.4% decline from 2022.
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $3.92M +$842K +27.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $4.11M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q3 2023 $3.33M -$407K -10.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $3.08M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q3 2022 $3.74M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.